Does INFLIXIMAB-QBTX Cause Off label use? 123 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 123 reports of Off label use have been filed in association with INFLIXIMAB-QBTX. This represents 42.6% of all adverse event reports for INFLIXIMAB-QBTX.
123
Reports of Off label use with INFLIXIMAB-QBTX
42.6%
of all INFLIXIMAB-QBTX reports
5
Deaths
32
Hospitalizations
How Dangerous Is Off label use From INFLIXIMAB-QBTX?
Of the 123 reports, 5 (4.1%) resulted in death, 32 (26.0%) required hospitalization, and 2 (1.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-QBTX. However, 123 reports have been filed with the FAERS database.
What Other Side Effects Does INFLIXIMAB-QBTX Cause?
Condition aggravated (57)
Arthralgia (28)
Intentional product use issue (25)
Uveitis (20)
Nausea (15)
Drug ineffective (13)
Nephrolithiasis (12)
Fatigue (11)
Fistula (10)
Malaise (10)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which INFLIXIMAB-QBTX Alternatives Have Lower Off label use Risk?
INFLIXIMAB-QBTX vs INFLIXIMAB, RECOMBINANT
INFLIXIMAB-QBTX vs INFLUENZA VIRUS VACCINE
INFLIXIMAB-QBTX vs INSULIN DEGLUDEC
INFLIXIMAB-QBTX vs INSULIN GLARGINE
INFLIXIMAB-QBTX vs INSULIN GLARGINE\LIXISENATIDE